Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study

BACKGROUND: Clinical remission can be maintained after the discontinuation of biological disease-modifying antirheumatic drugs (bDMARDs) in some patients with rheumatoid arthritis (RA) (bDMARD-free remission (BFR)). It is unknown which bDMARD is advantageous for achieving BFR or under which conditio...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashimoto, Motomu, Furu, Moritoshi, Yamamoto, Wararu, Fujimura, Takanori, Hara, Ryota, Katayama, Masaki, Ohnishi, Akira, Akashi, Kengo, Yoshida, Shuzo, Nagai, Koji, Son, Yonsu, Amuro, Hideki, Hirano, Toru, Ebina, Kosuke, Uozumi, Ryuji, Ito, Hiromu, Tanaka, Masao, Ohmura, Koichiro, Fujii, Takao, Mimori, Tsuneyo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091083/
https://www.ncbi.nlm.nih.gov/pubmed/30075810
http://dx.doi.org/10.1186/s13075-018-1673-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091083/
https://www.ncbi.nlm.nih.gov/pubmed/30075810
http://dx.doi.org/10.1186/s13075-018-1673-1

Ejemplares similares